You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/66016
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarona, H. R N-
dc.contributor.authorSchapoval, E. E S-
dc.date.accessioned2014-05-27T11:19:51Z-
dc.date.accessioned2016-10-25T18:16:07Z-
dc.date.available2014-05-27T11:19:51Z-
dc.date.available2016-10-25T18:16:07Z-
dc.date.issued1999-12-01-
dc.identifier.citationRevista de Ciencias Farmaceuticas, v. 20, n. 2, p. 301-333, 1999.-
dc.identifier.issn0101-3793-
dc.identifier.urihttp://hdl.handle.net/11449/66016-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/66016-
dc.description.abstractA revision was accomplished in the literature on the quinolones, antibacterial class that presents wide action spectrum, focusing, mainly, the sparfloxacin, third generation fluorquinolone which has potente activity against Gram positive organisms, including Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA), Gram negative organisms, Legionelia spp, Mycoplasma spp, Chlamydia spp and Mycobacterium spp, including multidrug resistant organisms.en
dc.format.extent301-333-
dc.language.isopor-
dc.sourceScopus-
dc.subjectAntibacterial activity-
dc.subjectFluoroquinolones-
dc.subjectQuinolones-
dc.subjectSparfloxacin-
dc.subjectantiinfective agent-
dc.subjectciprofloxacin-
dc.subjectfleroxacin-
dc.subjectirloxacin-
dc.subjectlevofloxacin-
dc.subjectlomefloxacin-
dc.subjectnadifloxacin-
dc.subjectnalidixic acid-
dc.subjectnorfloxacin-
dc.subjectofloxacin-
dc.subjectpefloxacin-
dc.subjectpefloxacin mesilate-
dc.subjectpipemidic acid-
dc.subjectquinoline derived antiinfective agent-
dc.subjectquinolone derivative-
dc.subjectrufloxacin-
dc.subjectsparfloxacin-
dc.subjecttrovafloxacin-
dc.subjectantibacterial activity-
dc.subjectdrug distribution-
dc.subjectdrug mechanism-
dc.subjectdrug structure-
dc.subjectdrug tolerability-
dc.subjectflatulence-
dc.subjectgastrointestinal symptom-
dc.subjectGram positive bacterium-
dc.subjecthuman-
dc.subjectnonhuman-
dc.subjectreview-
dc.subjectstructure activity relation-
dc.titleEsparfloxacino e as fluorquinolonas: Uma revisao de sua classificacao, atividade antibacteriana, mecanismo de acao, caracteristicas farmacocineticas, tolerabilidade e perspectivas farmaceuticaspt
dc.title.alternativeSparfloxacin and the flouroquinolones: A review of classification, antibacterial activity, mechanism of action, pharmacokinetic properties, tolerability and pharmaceutical perspectiveen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationDepto. de Farmacos e Medicamentos Faculdade de Ciencias Farmaceuticas UNESP, Araraquara, SP-
dc.description.affiliationUnespDepto. de Farmacos e Medicamentos Faculdade de Ciencias Farmaceuticas UNESP, Araraquara, SP-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofRevista de Ciencias Farmaceuticas-
dc.identifier.scopus2-s2.0-0033302426-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.